Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-08 4:15 pm Purchase |
2025-03-31 | 13G | Scilex Holding Company SCLX |
ORAMED PHARMACEUTICALS INC. ORMP |
732,717 9.900% |
289,860 (+65.45%) |
Filing History |
| 2025-01-23 9:21 pm Sale |
2025-01-21 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,302,484 21.100% |
-115,125 (-4.76%) |
Filing History |
| 2025-01-17 4:15 pm Purchase |
2025-01-13 | 13G | Scilex Holding Company SCLX |
ORAMED PHARMACEUTICALS INC. ORMP |
442,857 6.200% |
442,857 (New Position) |
Filing History |
| 2025-01-06 7:11 pm Sale |
2025-01-02 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,417,609 22.800% |
-142,857 (-5.58%) |
Filing History |
| 2024-09-09 4:11 pm Purchase |
2024-08-30 | 13D | DENALI CAP ACQUISITION CORP CL DNQAF |
Scilex Holding Co SCLX |
500,000 39.900% |
500,000 (New Position) |
Filing History |
| 2024-04-25 5:25 pm Unchanged |
2024-04-25 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,560,466 33.300% |
0 (Unchanged) |
Filing History |
| 2024-03-05 4:22 pm Unchanged |
2024-03-05 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,560,466 36.400% |
0 (Unchanged) |
Filing History |
| 2024-01-31 5:24 pm Unchanged |
2023-11-30 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,560,466 38.200% |
0 (Unchanged) |
Filing History |
| 2023-09-29 4:15 pm Purchase |
2023-09-21 | 13D | Scilex Holding Company SCLX |
SCLX Stock Acquisition JV LLC | 2,560,466 39.300% |
2,560,466 (New Position) |
Filing History |
| 2023-09-26 4:49 pm Sale |
2023-09-21 | 13D | Scilex Holding Company SCLX |
Sorrento Therapeutics Inc. SRNEQ |
54,777 1.300% |
-2,674,751 (-97.99%) |
Filing History |
| 2023-08-14 8:59 pm Unchanged |
2023-08-07 | 13D | Scilex Holding Company SCLX |
Sorrento Therapeutics Inc. SRNEQ |
2,729,529 43.300% |
0 (Unchanged) |
Filing History |
| 2023-03-03 09:10 am Unchanged |
2023-02-21 | 13D | Scilex Holding Company SCLX |
Sorrento Therapeutics Inc. SRNEQ |
2,729,529 44.200% |
0 (Unchanged) |
Filing History |
| 2023-02-13 1:52 pm Unchanged |
2022-12-31 | 13G | Scilex Holding Company SCLX |
Hudson Bay Capital Management LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-01-23 4:33 pm Sale |
2023-01-19 | 13D | Scilex Holding Company SCLX |
Sorrento Therapeutics Inc. SRNEQ |
2,729,529 45.500% |
-2,067,262 (-43.10%) |
Filing History |
| 2022-12-09 4:21 pm Sale |
2022-11-30 | 13G | Vickers Vantage Corp. I VCKA |
KARPUS MANAGEMENT, INC. | 0 0.000% |
-1,737,145 (Position Closed) |
Filing History |
| 2022-11-17 5:09 pm Purchase |
2022-11-10 | 13D | Scilex Holding Company SCLX |
Sorrento Therapeutics Inc. SRNEQ |
4,796,791 96.300% |
4,796,791 (New Position) |
Filing History |
| 2022-11-14 09:14 am Sale |
2022-11-09 | 13G | Vickers Vantage Corp. I VCKA |
Feis Lawrence | 0 0.000% |
-753,037 (Position Closed) |
Filing History |
| 2022-07-27 3:33 pm Purchase |
2022-07-26 | 13G | Vickers Vantage Corp. I VCKA |
Feis Lawrence | 753,037 5.720% |
753,037 (New Position) |
Filing History |
| 2022-02-14 3:28 pm Purchase |
2021-12-31 | 13G | Vickers Vantage Corp. I VCKA |
CVI Investments, Inc. | 749,600 4.300% |
749,600 (New Position) |
Filing History |
| 2022-02-11 2:19 pm Purchase |
2021-12-31 | 13G | Vickers Vantage Corp. I VCKA |
Shaolin Capital Management LLC | 1,325,779 7.700% |
1,325,779 (New Position) |
Filing History |